Charles Wu of Clyde & Co describes the current regulatory state of China's investment market, for private equity investors, including the much anticipated recent clarity provided by key regulators as well as potential pitfalls to avoid
May 22, 2024
Technology Media and Telecom
Procedures are facilitated for marketing of domestically produced foreign pharmaceuticals
May 17, 2024Successful U.S. IPO of Chinese EV brand suggests rising investor confidence, but regulatory risks still loom; Burberry wins trademark infringement and unfair competition lawsuit; and China proposes guidelines to it's lithium battery sector amid overcapacity concerns.
May 16, 2024SAMR specifies details on collecting electronic evidence
May 06, 2024Although CFIUS reviews have become more challenging for Chinese companies, transactions could still go ahead with a few tips in mind.
April 30, 2024China lifts foreign investment restrictions on value-added telecommunications services
April 25, 2024Na Wang and Yihui Liu, partners of Tian Yuan Law Firm, examine the Chinese securities regulator's key issues of concern with respect to overseas listings, and offer insights into the most recent regulatory trends
April 21, 2024China designates four pilot areas for foreign investment into telecommunications without ownership caps; CFIUS may be allowed to request more information on transactions that were not filed with them; and CSRC proposes tighter controls on programme trading
April 18, 2024Measures are laid out for handling of sensitive data by banking and insurance institutions
April 12, 2024
